Steward W P, Todd I D, Harris M, Jones J M, Blackledge G, Wagstaff J, Anderson H, Wilkinson P M, Crowther D
Eur J Cancer Clin Oncol. 1984 Jul;20(7):881-9. doi: 10.1016/0277-5379(84)90159-7.
One hundred and eleven patients with advanced-stage, high-grade histology non-Hodgkin's lymphoma were studied over a 7-yr period and were treated with one form of chemotherapy and radiotherapy. Multivariate analyses were carried out to identify factors which could predict a favourable prognosis. A complete response, low serum LDH and absence of clinical evidence of liver involvement were associated with long-term survival. The presence of 'B' symptoms, bone marrow involvement, low serum albumin and male sex predicted a reduced chance of achieving a complete remission. For those patients who achieved a complete response, the subdivision of histologies, particularly according to the Kiel classification, was the only significant factor predictive of prolonged relapse-free and overall survival. This confirms the importance of identifying different histological subgroups of lymphoma when considering treatment planning.
在7年的时间里,对111例晚期、高分级组织学非霍奇金淋巴瘤患者进行了研究,并采用了一种化疗和放疗形式进行治疗。进行多变量分析以确定可预测良好预后的因素。完全缓解、低血清乳酸脱氢酶以及无肝脏受累的临床证据与长期生存相关。“B”症状的存在、骨髓受累、低血清白蛋白和男性性别预示着完全缓解的机会降低。对于那些实现完全缓解的患者,组织学细分,特别是根据基尔分类法,是预测无复发生存期延长和总生存期延长的唯一重要因素。这证实了在考虑治疗方案时识别淋巴瘤不同组织学亚组的重要性。